These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28867619)

  • 1. Effect of sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime on Clostridium difficile surface layer protein A (slpA) gene expression.
    Zarandi ER; Mansouri S; Nakhaee N; Sarafzadeh F; Moradi M
    Microb Pathog; 2017 Oct; 111():163-167. PubMed ID: 28867619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxin production of Clostridium difficile in sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime.
    Zarandi ER; Mansouri S; Nakhaee N; Sarafzadeh F; Moradi M
    Microb Pathog; 2017 Jun; 107():249-253. PubMed ID: 28286152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin A and B genes expression of
    Moradi M; Mansouri S; Nakhaee N; Sarafzadeh F; Zarandi ER
    Iran J Microbiol; 2020 Feb; 12(1):18-24. PubMed ID: 32322375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
    Gerber M; Walch C; Löffler B; Tischendorf K; Reischl U; Ackermann G
    J Med Microbiol; 2008 Jun; 57(Pt 6):776-783. PubMed ID: 18480337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of
    Yang J; Yang H
    Front Microbiol; 2018; 9():2953. PubMed ID: 30564210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression.
    Denève C; Deloménie C; Barc MC; Collignon A; Janoir C
    J Med Microbiol; 2008 Jun; 57(Pt 6):732-738. PubMed ID: 18480330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization.
    Spigaglia P; Barketi-Klai A; Collignon A; Mastrantonio P; Barbanti F; Rupnik M; Janezic S; Kansau I
    J Med Microbiol; 2013 Sep; 62(Pt 9):1386-1393. PubMed ID: 23518658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex PCR targeting slpA: a rapid screening method to predict common Clostridium difficile ribotypes among fluoroquinolone resistant clinical strains.
    Xiao K; Kong F; Wang Q; Jin P; Thomas L; Xiong L; Zhou H; Gilbert GL
    Pathology; 2013 Oct; 45(6):595-9. PubMed ID: 24018815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models.
    Bruxelle JF; Mizrahi A; Hoys S; Collignon A; Janoir C; Péchiné S
    Anaerobe; 2016 Feb; 37():78-84. PubMed ID: 26505926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of the adaptive immune response to SlpA in Clostridium difficile infection.
    Mizrahi A; Bruxelle JF; Péchiné S; Le Monnier A
    Anaerobe; 2018 Dec; 54():164-168. PubMed ID: 30290246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.
    Aldape MJ; Rice SN; Field KP; Bryant AE; Stevens DL
    J Med Microbiol; 2018 Dec; 67(12):1689-1697. PubMed ID: 30307842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile.
    Merrigan MM; Venugopal A; Roxas JL; Anwar F; Mallozzi MJ; Roxas BA; Gerding DN; Viswanathan VK; Vedantam G
    PLoS One; 2013; 8(11):e78404. PubMed ID: 24265687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of teicoplanin against Clostridium difficile.
    Wongwanich S; Kusum M; Phan-Urai R
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of Clostridium difficile isolates.
    Dworczyński A; Sokół B; Meisel-Mikołajczyk F
    Cytobios; 1991; 65(262-263):149-53. PubMed ID: 1828756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.
    Adler A; Miller-Roll T; Bradenstein R; Block C; Mendelson B; Parizade M; Paitan Y; Schwartz D; Peled N; Carmeli Y; Schwaber MJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):21-4. PubMed ID: 26116225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.